|
|
Clinical observation of Mycoplasma pneumoniae infection and airway hyperresponsiveness |
RONG Jian-guo XU Jin-hui XIAO Xing |
Department of Pediatrics, Pingxiang Maternalty and Child Care, Jiangxi Province, Pingxiang 337000, China |
|
|
Abstract Objective To explore the relationship between Mycoplasma pneumoniae infection and airway hyperresponsiveness. Methods A total of 60 children with lower respiratory tract infection diagnosed as Mycoplasma pneumoniae infection in our hospital from October 2019 to January 2020 were selected into the observation group, and 60 children with lower respiratory tract infection diagnosed as non Mycoplasma pneumoniae infection in the same period were selected into the control group. The lung function indexes (forced vital capacity [FVC], forced expiratory volume in the first second [FEV1], FEV1/FVC, peak expiratory flow rate [PEF%], maximum voluntary ventilation [MVV], maximum mid-term expiratory flow [MMEF 25-75]) and serum IgE test results of children in the two groups were compared. According to the difference of serum specific IgG antibody titers, the observation group was divided into high titer group and low titer group, and the lung function indexes and serum IgE test results of children with different antibody titers were compared. Results The results of FVC, FEV1, FEV1/FVC, PEF%, MVV and MMEF 25-75 in the observation group were lower than those in the control group, and the serum IgE test results was higher than that in the control group, the differences were statistically significant (P<0.05). The results of FVC, FEV1, FEV1/FVC, PEF%, MVV and MMEF 25-75 in the high titer group were lower than those in the low titer group, and the serum IgE test results was higher than that in the low titer group, the differences were statistically significant (P<0.05). Conclusion Mycoplasma pneumoniae infection can reduce the lung function of children with lower respiratory tract infection and cause airway hyperresponsiveness, which needs to be diagnosed and treated as soon as possible.
|
|
|
|
|
[1] |
麦泽英,李柏.肺炎支原体感染与小儿反复呼吸道感染关系的临床分析[J].基层医学论坛,2019,23(4):502-504.
|
[2] |
王桢祥,李照虹.肺炎支原体与儿童反复呼吸道感染的关系及其临床重要性评价[J].中国处方药,2019,17(2):121-122.
|
[3] |
郑敏斯,何徳根,周永茂.儿童支气管哮喘与肺炎支原体感染关系的研究[J].中国现代药物应用,2019,13(21):32-34.
|
[4] |
胡亚美,江载芳.诸福棠实用儿科学[M].8 版.北京:人民卫生出版社,2012:15-16.
|
[5] |
刘欢.肺炎支原体感染诱发小儿哮喘的临床特征及对肺功能的影响[J].淮海医药,2019,37(4):387-389.
|
[6] |
王燕妮,韩鹏.哮喘患儿呼吸道支原体检出率对临床预后的影响[J].儿科药学杂志,2019,25(7):27-30.
|
[7] |
刘国荣,程春虹.气道反应性增高的危险因素分析[J].岭南急诊医学杂志,2011,16(6):424-426.
|
[8] |
雷丽,赵娟,陈丹,等.影响儿童哮喘气道高反应的危险因素分析[J].解放军医药杂志,2018,30(12):94-97.
|
[9] |
苏丽娜,吴守业,李文琳,等.肺炎支原体感染对哮喘患儿病情急性发作影响的可能机制分析[J].中华医院感染学杂志,2019,29(23):3651-3654,3660.
|
[10] |
王莉辉.小儿肺炎支原体感染后气道高反应临床诊治观察及护理研究[J].大家健康(学术版),2014,8(1):299.
|
[11] |
高海霞,王志勇.儿童反复呼吸道感染与自身免疫功能及气道高反应性的相关因素研究[J].河北医药,2012,34(17):2629-2630.
|
[12] |
Zhang H,Lv G,Shang Y,et al.Changes of Airway Reactivity after Mycoplasma Pneumoniae Infection in Children:A Study for Early Precautions against Pediatric Asthma[J].Iran J Allergy Asthma Immunol,2015,14(5):476-482.
|
[13] |
Watanabe H,Uruma T,Nakamura H,et al.The role of Mycoplasma pneumoniae infection in the initial onset and exacerbations of asthma[J].Allergy Asthma Proc,2014,35(3):204-210.
|
[14] |
谭伟.支气管哮喘与肺炎支原体感染的相关性分析[J].当代医药论丛,2018,16(13):82-83.
|
[15] |
许瑾.肺炎支原体抗体滴度测定在呼吸道感染患儿诊断中的临床意义[J].中国临床药理学杂志,2018,34(16):2001-2003.
|
[16] |
陈志铭,郭锡祥,梁艳芬.肺炎支原体抗体和IgE 与咳嗽变异性哮喘的相关性[J].中国城乡企业卫生,2019,34(11):118-120.
|
[17] |
甘瀛.雾化吸入盐酸氨溴索治疗小儿肺炎的临床疗效[J].中国现代医生,2019,57(12):60-62.
|
[18] |
张荣.阿奇霉素序贯疗法联合沙丁胺醇对肺炎支原体肺炎患儿炎症反应的影响[J].中国医药科学,2019,9(15):72-74,112.
|
|
|
|